CN202892459U - Novel antineoplastic pills - Google Patents

Novel antineoplastic pills Download PDF

Info

Publication number
CN202892459U
CN202892459U CN 201220496925 CN201220496925U CN202892459U CN 202892459 U CN202892459 U CN 202892459U CN 201220496925 CN201220496925 CN 201220496925 CN 201220496925 U CN201220496925 U CN 201220496925U CN 202892459 U CN202892459 U CN 202892459U
Authority
CN
China
Prior art keywords
layer
pills
powder
antineoplastic
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 201220496925
Other languages
Chinese (zh)
Inventor
温树启
于淑香
欧仁珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIANYUNGANG JARI PHARMACEUTICAL CO Ltd
Original Assignee
LIANYUNGANG JARI PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIANYUNGANG JARI PHARMACEUTICAL CO Ltd filed Critical LIANYUNGANG JARI PHARMACEUTICAL CO Ltd
Priority to CN 201220496925 priority Critical patent/CN202892459U/en
Application granted granted Critical
Publication of CN202892459U publication Critical patent/CN202892459U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The utility model relates to the technical field of pills, in particular to novel antineoplastic pills, which comprise five layers. The five layers of the antineoplastic pills comprise that a first layer which is a mixture of grape fruit powder and Chinese chive seed powder, a second layer which is the mixture of glossy privet fruit powder, pseudo-ginseng powder and atractylodes lancea powder, a third layer which is a sugar coated layer, a fourth layer which is the mixture of bitter gourd powder and orange peel powder and a fifth layer which is the sugar coated layer from the inside to the outside. When the novel antineoplastic pills are used, the level of the pills is arranged reasonably, the novel antineoplastic pills can be sequentially released respectively and used in a matching way according to the drug properties of different drugs, and a release rate is slow, so that a best medicinal effect of the pills can be given full play. The novel antineoplastic pills have the advantages of simple structure, reasonability in arrangement, good medicinal effect, little side effect and the like.

Description

A kind of novel antineoplastic pill
Technical field
This utility model relates to the pill technical field, particularly a kind of novel antineoplastic pill.
Background technology
At present, tumor disease is the formidable enemy of harmful to human, because Therapeutic Method is limited, thereby dead ratio is higher, so people always talk the cancer complexion changed.Mainly be that operation adds chemotherapy to the effective Therapeutic Method of cancer now, but this method is very large to the injury of human body, particularly chemotherapy more has a lot of side effect.And along with the reach of science, the medicine of its treatment cancer is also a lot, such as Western medicine, Chinese medicine etc., although these medicines have certain effect to the treatment cancer, long-term taking also has certain harm to health, thereby unsuitable long-term taking.Use at present the antineoplastic pill of vegetable and melon and fruit then seldom.
The utility model content
The purpose of this utility model is for the defective of prior art and deficiency, provides a kind of level that antineoplastic pill scientific and reasonable, that can slowly discharge and can bring into play optimum medicine efficacy is set.
For achieving the above object, the technical solution adopted in the utility model is:
A kind of novel antineoplastic pill described in the utility model, five layers of described antineoplastic pill are provided with ground floor, the second layer, the 3rd layer, the 4th layer and layer 5 from the inside to the outside successively, the skin of described ground floor is fitting tightly the second layer, the skin of the described second layer is fitting tightly the 3rd layer, described the 3rd layer skin is fitting tightly the 4th layer, and described the 4th layer skin is fitting tightly layer 5; Ground floor is mixed by Fructus Vitis viniferae powder and leek seed powder, and the second layer is mixed by Fructus Ligustri Lucidi powder, Radix Notoginseng powder and Rhizoma Atractylodis powder, and the 4th layer for Fructus Momordicae charantiae powder and orange meal mix, and the 3rd layer and layer 5 are sugarcoating layer.
Further, described antineoplastic pill is spheroidal.
After adopting said structure, this utility model beneficial effect is: a kind of novel antineoplastic pill described in the utility model, comprise five layers, five layers of described antineoplastic pill are respectively from the inside to the outside: ground floor is the Fructus Vitis viniferae powder, the mixture of leek seed powder, the described second layer is Fructus Ligustri Lucidi powder, Radix Notoginseng powder, the mixture of Rhizoma Atractylodis powder, described the 3rd layer is sugarcoating layer, described the 4th layer is Fructus Momordicae charantiae powder, the mixture of orange meal, described layer 5 is sugarcoating layer, when using this utility model, because level arranges rationally, can successively discharge respectively according to the property of medicine of different pharmaceutical and be used in conjunction with, and rate of release is slow, thereby can bring into play the optimum medicine efficacy of medicine.The utlity model has simple in structurely, arrange rationally, the advantage such as good drug efficacy, side effect are little.
Description of drawings
Fig. 1 is structural representation of the present utility model;
Description of reference numerals:
1, ground floor; 2, the second layer; 3, the 3rd layer;
4, the 4th layer; 5, layer 5.
The specific embodiment
Below in conjunction with accompanying drawing this utility model is further described.
As shown in Figure 1, a kind of novel antineoplastic pill described in the utility model, five layers of described antineoplastic pill are provided with ground floor 1, the second layer 2, the 3rd layer 3, the 4th layers 4 and layer 55 from the inside to the outside successively, the skin of described ground floor 1 is fitting tightly the second layer 2, the skin of the described second layer 2 is fitting tightly the 3rd layer 3, described the 3rd layer 3 skin is fitting tightly the 4th layer 4, and described the 4th layer 4 skin is fitting tightly layer 55; Ground floor 1 is mixed by Fructus Vitis viniferae powder and leek seed powder, and the second layer 2 is mixed by Fructus Ligustri Lucidi powder, Radix Notoginseng powder and Rhizoma Atractylodis powder, and the 4th layer 4 for Fructus Momordicae charantiae powder and orange meal mix, and the 3rd layer 3 and layer 55 are sugarcoating layer.Arrange like this, take Fructus Momordicae charantiae powder, orange meal as principal agent, other is aided with Fructus Ligustri Lucidi powder, Radix Notoginseng powder, Rhizoma Atractylodis powder etc. again with Fructus Vitis viniferae powder, leek seed powder, deficiency and excess is taken into account, and cold-damp and profit counteract each other, can improve body immunity, can spread by anticancer, cancer cell tissue be destroyed disintegrate.Antineoplastic pill described in the utility model uses through hospital clinical simultaneously, and proving has certain curative effect to multiple cancers such as breast carcinoma, gastric cancer, esophageal carcinoma.
As a kind of optimal way of the present utility model, described antineoplastic pill is spheroidal, adopts spheroidal so that the property of medicine can successively slowly discharge, thus the performance optimum medicine efficacy.
When taking with this utility model, because level arranges rationally, can successively discharge respectively according to the property of medicine of different pharmaceutical and be used in conjunction with, and rate of release is slow, thereby can brings into play the optimum medicine efficacy of medicine.In addition, this is simple in structure, reasonable in design, and good drug efficacy, side effect are little.
The above only is better embodiment of the present utility model, therefore all equivalences of doing according to the described structure of this utility model patent claim, feature and principle change or modify, is included in this utility model patent claim.

Claims (2)

1. novel antineoplastic pill, comprise five layers, it is characterized in that: five layers of described antineoplastic pill are provided with ground floor (1), the second layer (2), the 3rd layer (3), the 4th layer (4) and layer 5 (5) from the inside to the outside successively, the skin of described ground floor (1) is fitting tightly the second layer (2), the skin of the described second layer (2) is fitting tightly the 3rd layer (3), the skin of described the 3rd layer (3) is fitting tightly the 4th layer (4), and the skin of described the 4th layer (4) is fitting tightly layer 5 (5); The 3rd layer (3) and layer 5 (5) are sugarcoating layer.
2. a kind of novel antineoplastic pill according to claim 1, it is characterized in that: described antineoplastic pill is spheroidal.
CN 201220496925 2012-09-26 2012-09-26 Novel antineoplastic pills Expired - Fee Related CN202892459U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201220496925 CN202892459U (en) 2012-09-26 2012-09-26 Novel antineoplastic pills

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201220496925 CN202892459U (en) 2012-09-26 2012-09-26 Novel antineoplastic pills

Publications (1)

Publication Number Publication Date
CN202892459U true CN202892459U (en) 2013-04-24

Family

ID=48113184

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201220496925 Expired - Fee Related CN202892459U (en) 2012-09-26 2012-09-26 Novel antineoplastic pills

Country Status (1)

Country Link
CN (1) CN202892459U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105833125A (en) * 2016-04-26 2016-08-10 荣俊 Traditional Chinese medicine pill for treating stomach illness

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105833125A (en) * 2016-04-26 2016-08-10 荣俊 Traditional Chinese medicine pill for treating stomach illness

Similar Documents

Publication Publication Date Title
CN102698034A (en) Traditional Chinese medicine composition for treating constipation
CN101301352A (en) Chinese medicinal preparation for treating cancer and preparation
CN102861193A (en) Traditional Chinese medicine composition for treating gastric cancer
CN102755600B (en) Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence, preparation method and uses
CN102204983B (en) Medicament for treating urticaria
CN101810337A (en) Health food containing pseudo-ginseng and ganoderma lucidum and radix astragali
CN202892459U (en) Novel antineoplastic pills
CN102188612A (en) Traditional Chinese medicine for treating diabetes mellitus and preparation method thereof
CN103550718B (en) A kind of Chinese medicine composition for the treatment of pulmonary carcinoma
CN103272159B (en) Chinese herbal preparation used for treating consumptive disease and preparation method thereof
CN102872385B (en) Compound Chinese medicinal composition for treating advanced gastric cancer and preparation method and application thereof
CN101623455B (en) Medicine for treating prostate hyperplasia
CN1162172C (en) Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia
CN201542984U (en) Antineoplastic pill
CN100411663C (en) Anticancer compound Chinese medicine powder and its preparing method
CN104738629A (en) Health food with functions of lubricating intestines and relaxing bowels
CN104082730A (en) Micro-ecologic special diet for ovarian cancer patients
CN103479744A (en) Traditional Chinese medicine composition with functions of soothing liver and maintaining beauty
CN102920907A (en) Traditional Chinese medicine for treating diabetes
CN102755560B (en) Traditional Chinese medicine compound reducing chemotherapy side reaction and preparation method and application thereof
CN103638336A (en) Full rhizoma gastrodiae tablet
CN102614235A (en) Acanthopanax root tea paste and preparation method thereof
CN101637581A (en) Chinese medicinal composition for treating gastric cancer
CN102716439A (en) Traditional Chinese medicine for treating atrophic gastritis
CN102178221B (en) Cordyceps militaris composite nutrition composition capable of improving defecation function and preparation method thereof

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130424

Termination date: 20150926

EXPY Termination of patent right or utility model